Abstract:Icariin, a flavonoid glycoside, is extracted from Epimedium. This study aimed to investigate the vascular protective effects of icariin in type 1 diabetic rats by inhibiting high-mobility group box 1 (HMGB1)-related inflammation and exploring its potential mechanisms. The impact of icariin on vascular dysfunction was assessed in streptozotocin (STZ)-induced diabetic rats through vascular reactivity studies. Western blotting and immunofluorescence assays were performed to measure the expressions of target proteins. The release of HMGB1 and pro-inflammation cytokines were measured by enzyme-linked immunosorbent assay (ELISA). The results revealed that icariin administration enhanced acetylcholine-induced vasodilation in the aortas of diabetic rats. It also notably reduced the release of pro-inflammatory cytokines, including interleukin-8 (IL-8), IL-6, IL-1β, and tumor necrosis factor-alpha (TNF-α) in diabetic rats and high glucose (HG)-induced human umbilical vein endothelial cells (HUVECs). The results also unveiled that the pro-inflammatory cytokines in the culture medium of HUVECs could be increased by rHMGB1. The increased release of HMGB1 and upregulated expressions of HMGB1-related inflammatory factors, including advanced glycation end products (RAGE), Toll-like receptor 4 (TLR4), and phosphorylated p65 (p-p65) in diabetic rats and HG-induced HUVECs, were remarkably suppressed by icariin. Notably, HMGB1 translocation from the nucleus to the cytoplasm in HUVECs under HG was inhibited by icariin. Meanwhile, icariin could activate G protein-coupled estrogen receptor (GPER) and sirt1. To explore the role of GPER and Sirt1 in the inhibitory effect of icariin on HMGB1 release and HMGB-induced inflammation, GPER inhibitor and Sirt1 inhibitor were used in this study. These inhibitors diminished the effects of icariin on HMGB1 release and HMGB1-induced inflammation. Specifically, the GPER inhibitor also negated the activation of Sirt1 by icariin. These findings suggest that icariin activates GPER and increases the expression of Sirt1, which in turn reduces HMGB1 translocation and release, thereby improving vascular endothelial function in type 1 diabetic rats by inhibiting inflammation.

Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-κB and JNK/p38 MAPK pathways

Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1.

Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-κB signaling pathway

Icariin Inhibits LPS-induced Cell Inflammatory Response by Promoting GRα Nuclear Translocation and Upregulating GRα Expression.

Icariin and Icaritin Ameliorated Hippocampus Neuroinflammation Via Inhibiting HMGB1-related Pro-Inflammatory Signals in Lipopolysaccharide-Induced Inflammation Model in C57BL/6 J Mice.

Icariin Derivative Inhibits Inflammation Through Suppression Of P38 Mitogen-Activated Protein Kinase And Nuclear Factor-Kappa B Pathways

Effects of icariin on inflammation model stimulated by lipopolysaccharide in vitro and in vivo]

Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro

IGF-1 receptor is involved in the regulatory effects of icariin and icaritin in astrocytes under basal conditions and after an inflammatory challenge

Icariin Protects H9c2 Cardiomyocytes from Lipopolysaccharide-Induced Injury Via Inhibition of the Reactive Oxygen Species-Dependent C-Jun N-terminal Kinases/nuclear Factor-Κb Pathway

Icariin Attenuates Vascular Endothelial Dysfunction by Inhibiting Inflammation Through GPER/Sirt1/HMGB1 Signaling Pathway in Type 1 Diabetic Rats

Icariin inhibits demyelination by targeting the phagecytic activity of microglia in CPZ-induced demyelinating mice

P104 Icariin Attenuates Intestinal Inflammation through Inhibition of the Nuclear Factor-ĸB signaling

Icariin Prevents IL-1 β -Induced Apoptosis in Human Nucleus Pulposus via the PI3K/AKT Pathway.

Icariin ameliorates the cuprizone-induced demyelination associated with antioxidation and anti-inflammation

Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells

Icariin Exerts an Antidepressant Effect in an Unpredictable Chronic Mild Stress Model of Depression in Rats and is Associated with the Regulation of Hippocampal Neuroinflammation.

Icariin protects against cerebral ischemia / reperfusion injury by activating the PI 3 K / Akt signaling pathway

Icariin Ameliorates Behavioral Deficits and Neuropathology in a Mouse Model of Multiple Sclerosis

Icariin Prevents Il-1 Beta-Induced Apoptosis In Human Nucleus Pulposus Via The Pi3k/Akt Pathway

Icariin attenuates ischaemic stroke through suppressing inflammation mediated by endoplasmic reticulum stress signalling pathway in rats